Document is current
Any future updates will be listed below
-
Authors
Kim, Ryan
Kittipibul, Veraprapas
Bhatt, Sapna
Fudim, Marat
- License Information
-
More Information
Article History
Accepted: 26 March 2025
First Online: 4 April 2025
Declarations
:
: Dr Fudim was supported by the NIH, Bodyport, Sardocor, and Doris Duke. He is a consultant/has ownership interesting in Abbott, Ajax, Alio Health, Alleviant, Analog, Andera, Artha, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardioflow, Coridea, CVRx, Daxor, Edwards LifeSciences, Echosens, EKO, Feldschuh Foundation, Fire1, FutureCardia, Galvani, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, Intershunt, Medtronic, Merck, NIMedical, NovoNordisk, NucleusRx, NXT Biomedical, Orchestra, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, ReCor, Rockley, SCPharma, Shifamed, Splendo, STAT Health, Summacor, SyMap, Verily, Vironix, Viscardia, Zoll. Other authors report no relevant disclosures.
